Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States
3 other identifiers
interventional
144
1 country
4
Brief Summary
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable interventions to identify, recruit, link to care, retain in care, attain, and maintain viral suppression among HIV-infected men who have sex with men (MSM) in the United States (US).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv
Started Jun 2016
Typical duration for not_applicable hiv
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2016
CompletedFirst Posted
Study publicly available on registry
January 26, 2016
CompletedStudy Start
First participant enrolled
June 6, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 8, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 8, 2019
CompletedMarch 25, 2025
March 1, 2025
2.7 years
January 13, 2016
March 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
HIV status at screening for each MSM recruited
HIV status
At Baseline
HIV viral load at screening for each MSM recruited
HIV viral load
12 months
HIV viral load at month 24 of participants randomized
time driven HIV viral load
24 months
Secondary Outcomes (11)
Date of recruitment for each man recruited by DC-RDS
During recruitment period
Wave of recruitment for each man recruited by DC-RDS
During recruitment period
HIV viral load of those randomized
HIV viral load at Months 3, 6, 9, 12
Number of all care visits from randomization through the end of 12 months follow up
Over 12 months
Time of all care visits from randomization through the end of 12 months follow up
Over 12 months
- +6 more secondary outcomes
Other Outcomes (6)
Health care utilization at baseline and 24 months
Up to 24 months
Stigma at baseline and 24 months
Up to 24 months
Number of contacts (text message, email, phone, in person) for each participant randomized to the CM intervention arm over follow-up
Up to 24 months
- +3 more other outcomes
Study Arms (2)
Intervention
EXPERIMENTALThe intervention arm will provide a Case Manager (CM) intervention package designed to enhance linkage to care, antiretroviral treatment (ART) initiation, treatment adherence and retention in care.
Control
NO INTERVENTIONStandard of care
Interventions
The intervention arm will provide a Case Manager (CM) intervention package designed to enhance linkage to care, antiretroviral treatment (ART) initiation, treatment adherence and retention in care.
Eligibility Criteria
You may qualify if:
- Individuals who meet all of the following criteria are eligible for study screening:
- Biological male (at birth)
- Self-report of history of anal intercourse with another man
- years or older
- Individuals who are eligible for screening and who meet all of the following criteria are eligible for enrollment into the CM intervention and SOC control arms:
- HIV-infected, as defined in the HPTN 078 Study-Specific Procedures (SSP) Manual
- Not virally suppressed (defined as HIV VL ≥ 1000 copies/ml)
- Can receive HIV care at one of the participating clinics (as chosen by each site)
- No current plan to relocate in the 24 months following enrollment
You may not qualify if:
- Individuals who meet any of the following criteria will be excluded from study screening:
- Unable or unwilling to provide consent/assent for study participation.
- Active or previous participation in an HIV vaccine trial.
- Any condition that, in the opinion of the Investigator of Record (IoR), would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
- Individuals who are eligible for screening, but who meet the following criteria are excluded from enrollment into the CM intervention and SOC control arms:
- Current participation in a linkage or ART adherence study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Alabama CRS
Birmingham, Alabama, 35294, United States
Ponce de Leon CRS
Atlanta, Georgia, 30308-2012, United States
Johns Hopkins Baltimore CRS
Baltimore, Maryland, 21287, United States
Fenway Health CRS
Boston, Massachusetts, 02215-4302, United States
Related Publications (2)
KM Mitchell, B Hoots, D Dimitrov, et al. Potential Impact on HIV Incidence of Increasing Viral Suppression among HIV- positive MSM in Baltimore: Mathematical Modelling for HPTN 078. HIV Research for Prevention (HIVR4P 2016). Chicago, October 17-21, 2016. Abstract OA10.04
BACKGROUNDMaragh-Bass AC, Hucks-Ortiz C, Beyrer C, Remien RH, Mayer K, Del Rio C, Batey DS, Farley JE, Gamble T, Tolley EE. Multilevel Stigma and Its Associations with Medical Care Ratings Among Men Who Have Sex With Men in HPTN 078. J Prim Care Community Health. 2023 Jan-Dec;14:21501319231175362. doi: 10.1177/21501319231175362.
PMID: 37243342DERIVED
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Chris Beyrer, MD/MPH
Johns Hopkins University
- STUDY CHAIR
Robert H Remien, PhD
Columbia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2016
First Posted
January 26, 2016
Study Start
June 6, 2016
Primary Completion
February 8, 2019
Study Completion
February 8, 2019
Last Updated
March 25, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share